Private Trust Company’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21K Buy
217
+40
+23% +$4.1K ﹤0.01% 1672
2025
Q4
$18.8K Hold
177
﹤0.01% 1684
2025
Q3
$22.5K Hold
177
﹤0.01% 1591
2025
Q2
$21.7K Sell
177
-48
-21% -$5.48K ﹤0.01% 1531
2025
Q1
$22.8K Buy
225
+81
+56% +$7.91K ﹤0.01% 1500
2024
Q4
$13.3K Buy
+144
New +$14.1K ﹤0.01% 1653
2014
Q4
Sell
-53
Closed -$2K 534
2014
Q3
$2K Hold
53
﹤0.01% 1582
2014
Q2
$2K Hold
53
﹤0.01% 1583
2014
Q1
$2K Sell
53
-30
-36% -$781 ﹤0.01% 1470
2013
Q4
$2K Hold
83
﹤0.01% 1452
2013
Q3
$2K Hold
83
﹤0.01% 1400
2013
Q2
$2K Buy
+83
New +$1.88K ﹤0.01% 1327

Other funds holding EHC

Private Trust Company's EHC Position: Q1 2026 in Review

Private Trust Company increased its Encompass Health (EHC) stake by 23% in Q1 2026, buying an estimated $4.1K and bringing the position to 217 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

Private Trust Company first reported a position in EHC in Q2 2013 and has held it in 12 quarters since. The position peaked at $22.8K in Q1 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Private Trust Company held 217 shares of Encompass Health worth $21K as of Q1 2026.
  • Private Trust Company bought 40 Encompass Health shares in Q1 2026, an estimated $4.1K.
  • Encompass Health made up ﹤0.01% of Private Trust Company's portfolio in Q1 2026, its #1672 holding.
  • Private Trust Company first reported a position in Encompass Health in Q2 2013 and has held it in 12 quarters since.
  • Private Trust Company's Encompass Health position peaked at $22.8K in Q1 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.